Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALVOW | US
0
0%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
2.98
3.10
3.10
2.98
Alvotech Holdings SA through its subsidiaries develops and manufactures biosimilars for global markets. The company is based in Iceland.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
76.7%1 month
71.8%3 months
112.7%6 months
111.0%-
-
-
-1.96
1.11
-
-
-
-104.55M
-
-
-
46.22
-69.60
4.40K
-
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.60
Range1M
0.60
Range3M
2.58
Rel. volume
0.54
Price X volume
596.00
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.103 | 0 | -0.96% | n/a | 2.46% |
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.02 | 0 | n/a | 13.20% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 17.21 | - |
Ent. to Revenue | - | 334.38 | - |
PE Ratio | - | 26.92 | - |
Price to Book | - | 12.15 | - |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 112.75 | 68.34 | Riskier |
Debt to Equity | -1.96 | -1.00 | Cheaper |
Debt to Assets | 1.11 | 0.48 | Expensive |
Market Cap | - | 5.31B | - |